tiprankstipranks
Trending News
More News >
Spruce Biosciences (SPRBD)
OTHER OTC:SPRBD
US Market
Advertisement

Spruce Biosciences (SPRBD) Stock Forecast & Price Target

Compare
325 Followers
See the Price Targets and Ratings of:

SPRBD Financial Forecast

No data currently available

SPRBD Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

SPRBD Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on SPRBD
Leerink Partners
Leerink Partners
$1
Hold
-89.98%
Downside
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Adicet Bio (NASDAQ: ACET) and Spruce Biosciences (Other OTC: SPRB)
RBC Capital Analyst forecast on SPRBD
RBC Capital
RBC Capital
$0.5
Hold
-94.99%
Downside
Reiterated
05/06/25
Analysts Conflicted on These Healthcare Names: Spruce Biosciences (Other OTC: SPRB), Cigna (NYSE: CI) and Axsome Therapeutics (NASDAQ: AXSM)
TR | OpenAI - 4o Analyst forecast on SPRBD
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/29/25
Citizens JMP Analyst forecast on SPRBD
Citizens JMP
Citizens JMP
Hold
Reiterated
04/23/25
Citizens JMP reiterates Market Perform Rating on Spruce Biosciences, Inc. (SPRB)Citizens JMP analyst Jonathan Wolleben reiterated a Market Perform rating and {REMOVEPT} price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).
Oppenheimer Analyst forecast on SPRBD
Oppenheimer
Oppenheimer
Hold
Downgraded
12/11/24
Spruce Biosciences Downgraded to Hold Amid Unmet Clinical Trial Endpoints and Strategic Reevaluation
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on SPRBD
Leerink Partners
Leerink Partners
$1
Hold
-89.98%
Downside
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Adicet Bio (NASDAQ: ACET) and Spruce Biosciences (Other OTC: SPRB)
RBC Capital Analyst forecast on SPRBD
RBC Capital
RBC Capital
$0.5
Hold
-94.99%
Downside
Reiterated
05/06/25
Analysts Conflicted on These Healthcare Names: Spruce Biosciences (Other OTC: SPRB), Cigna (NYSE: CI) and Axsome Therapeutics (NASDAQ: AXSM)
TR | OpenAI - 4o Analyst forecast on SPRBD
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/29/25
Citizens JMP Analyst forecast on SPRBD
Citizens JMP
Citizens JMP
Hold
Reiterated
04/23/25
Citizens JMP reiterates Market Perform Rating on Spruce Biosciences, Inc. (SPRB)Citizens JMP analyst Jonathan Wolleben reiterated a Market Perform rating and {REMOVEPT} price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).
Oppenheimer Analyst forecast on SPRBD
Oppenheimer
Oppenheimer
Hold
Downgraded
12/11/24
Spruce Biosciences Downgraded to Hold Amid Unmet Clinical Trial Endpoints and Strategic Reevaluation
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Spruce Biosciences

1 Month
No data currently available
3 Months
No data currently available
1 Year
Dex GenotekTR | OpenAI - 4o
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.10%
reiterated a sell rating 4 months ago
Copying Dex Genotek's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.10% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SPRBD Analyst Recommendation Trends

Rating
Nov 24
Dec 24
Jan 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
2
3
2
2
0
Hold
7
10
10
11
7
Sell
2
4
5
4
2
Strong Sell
0
0
0
0
0
total
11
17
17
17
9
In the current month, SPRBD has received 0 Buy Ratings, 7 Hold Ratings, and 2 Sell Ratings. SPRBD average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SPRBD Stock Forecast FAQ

What is SPRBD’s average 12-month price target, according to analysts?
Currently, no data Available
What is SPRBD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SPRBD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SPRBD a Buy, Sell or Hold?
      Currently, no data Available
      What is Spruce Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Spruce Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SPRBD?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis